140
Participants
Start Date
January 15, 2026
Primary Completion Date
August 31, 2029
Study Completion Date
August 31, 2029
Pacemaker lead
The pacemaker lead under investigation is a bipolar, steroid-releasing pacemaker electrode with active fixation (IS-1 connection) designed for chronic stimulation and sensing in the right atrium, right ventricle or left bundle branch area (LBBA). In this study, the lead is implanted in the LBBA and connected to a single- or dual-chamber pacemaker. Implantation is performed using a compatible, CE-marked catheter for pacemaker implantation.
Lead Sponsor
Boston Scientific Corporation
INDUSTRY